Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The FDA has approved Qsymia TM (Phentermine + Topiramate) for long-term weight management in adults. This is for those with a BMI of 30 kg/m² or higher, or a BMI of 27 kg/m² or higher with at least one weight-related health issue. It should be used with a low-calorie diet and more physical activity. The FDA also approved its use for children aged 12 and older with obesity for long-term weight management, also alongside diet and exercise.
[fda-approves-treatment-chronic-weight-management-pediatric-patients-aged-12-years-and-older](https://www.fda.gov/drugs/news-events-human-drugs/fda-appro…